CD8+ T cells recognize specific tumor antigens presented via major histocompatibility complex class I (MHC-I) molecules, triggering the secretion of cytotoxic molecules and effector cytokines [e.g. interferon gamma (IFN-γ)] that result in the immune killing of the target cell. The gene discussed is IFNG; the disease is neoplasm.